BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 18672665)

  • 21. Management considerations for the adult with congenital adrenal hyperplasia.
    Auchus RJ
    Mol Cell Endocrinol; 2015 Jun; 408():190-7. PubMed ID: 25643980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.
    Merke D; Kabbani M
    Paediatr Drugs; 2001; 3(8):599-611. PubMed ID: 11577925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital adrenal hyperplasia.
    Witchel SF; Azziz R
    J Pediatr Adolesc Gynecol; 2011 Jun; 24(3):116-26. PubMed ID: 21601808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in 21-hydroxylase deficiency.
    New MI; Levine LS
    Annu Rev Med; 1984; 35():649-63. PubMed ID: 6372675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acne and non-classic congenital adrenal hyperplasia.
    Falhammar H
    N Z Med J; 2008 Jun; 121(1275):94-5. PubMed ID: 18551162
    [No Abstract]   [Full Text] [Related]  

  • 26. Bilateral adrenal myelolipoma associated with adrenogenital syndrome.
    Sakaki M; Izaki H; Fukumori T; Taue R; Kishimoto T; Kanayama HO
    Int J Urol; 2006 Jun; 13(6):801-2. PubMed ID: 16834664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report.
    Sumińska M; Bogusz-Górna K; Wegner D; Fichna M
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Nimkarn S; New MI
    Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):99-105. PubMed ID: 17342026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Fujieda K; Mukai T
    Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From gene to disease: adrenogenital syndrome and the CYP21A2 gene].
    Claahsen-van der Grinten HL; Hoefsloot LH
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1174-7. PubMed ID: 17557757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How can molecular biology contribute to the management of congenital adrenal hyperplasia?
    Ritzén EM; Lajic S; Wedell A
    Horm Res; 2000; 53 Suppl 1():34-7. PubMed ID: 10895040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Steroid 21-hydroxylase deficiency, the most frequent cause of congenital adrenal hyperplasia].
    Doleschall M; Török D; Mészáros K; Luczay A; Halász Z; Németh K; Szücs N; Kiss R; Tőke J; Sólyom J; Fekete G; Patócs A; Igaz P; Tóth M
    Orv Hetil; 2018 Feb; 159(7):269-277. PubMed ID: 29429350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
    Wedell A
    Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Bachelot A; Touraine P
    Presse Med; 2014 Apr; 43(4 Pt 1):428-37. PubMed ID: 24630263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polycystic ovary syndrome and congenital adrenal hyperplasia: a different entity for comparable phenotypes?].
    Robyr D; Llor J; Gaudin G; Schneider N
    Rev Med Suisse; 2007 Jun; 3(116):1595-6, 1598, 1600-1. PubMed ID: 17727172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L; Quitter F; Hübner A; Reisch N
    Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.
    Wilson RC; Mercado AB; Cheng KC; New MI
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2322-9. PubMed ID: 7629224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.
    Gidlöf S; Falhammar H; Thilén A; von Döbeln U; Ritzén M; Wedell A; Nordenström A
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):35-42. PubMed ID: 24622265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
    Stikkelbroeck MM; Otten BJ
    Ned Tijdschr Geneeskd; 2002 Feb; 146(6):246-9. PubMed ID: 11865652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
    New MI
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4205-14. PubMed ID: 16912124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.